[{"Assets_0_Q1_USD":59854000000.0,"CommonStockSharesConverted_0_Q1_shares":1198000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":112000000.0,"NetIncomeLossConverted_1_Q1_USD":-97000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1090000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1090000000.0,"StockholdersEquity_0_Q1_USD":14732000000.0,"StockholdersEquityConverted_0_Q1_USD":15821000000.0,"EarningsPerShareBasic_1_Q1_USD":-0.1,"EarningsPerShareDiluted_1_Q1_USD":-0.1,"RevenuesConverted_1_Q1_USD":4295000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190502"}]